X hits on this document





261 / 316

   the Commissioner,  in consultation with  the Administrator, to  be

   necessary for use in medical devices.

      "(3)  Aviation safety.-(A)  Notwithstanding the  termination of

   production required  by subsection (b),  the Administrator,  after

   notice and  opportunity for  public  comment, may,  to the  extent

   such action  is consistent with  the Montreal Protocol,  authorize

   the    production    of    limited   quantities    of   halon-1211

   (bromochlorodifluoromethane),     halon-1301      (bromotrifluoro-

   methane),  and  halon-2402 (dibromotetrafluoroethane)  solely  for

   purposes  of aviation safety if  the Administrator  of the Federal

   Aviation Administration, in consultation  with the  Administrator,

   determines  that  no  safe  and  effective   substitute  has  been

   developed and  that such authorization  is necessary for  aviation

   safety purposes.

      "(B) The  Administrator of the Federal  Aviation Administration

   shall, in  consultation with  the  Administrator, examine  whether

   safe   and   effective  substitutes   for  methyl   chloroform  or

   alternative  techniques  will  be  available   for  nondestructive

   testing  for metal  fatigue  and  corrosion of  existing  airplane

   engines  and  airplane  parts susceptible  to  metal  fatigue  and

   whether  an exception  for such  uses of  methyl chloroform  under

   this paragraph  will be  necessary for purposes  of airline safety

   after January 1, 2005 and provide a report to Congress in 1998.

      "(4) Cap on certain  exceptions.-Under no circumstances may the

   authority set forth in paragraphs (1), (2), and (3) of sub-

   section  (d) be applied to authorize any person to produce a class

   I substance in annual quantities  greater than 10 percent  of that

   produced by such person during the baseline year.

   "(e) Developing Countries.-

      "(1) Exception.-Notwithstanding the  phase-out and  termination

   of  production  required  under  subsections  (a)   and  (b),  the

   Administrator, after  notice and  opportunity for public  comment,

   may,  consistent  with   the  Montreal  Protocol,   authorize  the

   production of limited  quantities of a class I substance in excess

   of  the amounts  otherwise allowable under  subsection (a) or (b),

   or both,  solely for export to,  and use  in, developing countries

   that are Parties  to the Montreal Protocol and are operating under

   article  5 of such Protocol. Any  production authorized under this

   paragraph shall  be solely  for purposes of  satisfying the  basic

   domestic needs of such countries.

      "(2)  Cap  on exception.-(A)  Under  no  circumstances may  the

   authority set forth in paragraph  (1) be applied to  authorize any

   person to produce  a class  I substance in  any year  for which  a

   production  percentage is  specified in Table  2 of subsection (a)

   in  an annual quantity greater than the specified percentage, plus

   an  amount equal  to 10  percent of  the amount  produced by  such

   person in the baseline year.

      "(B)  Under no  circumstances may  the authority  set  forth in

   paragraph (1)  be applied  to authorize  any person  to produce  a

   class I substance  in the applicable termination  year referred to

   in  subsection  (b), or  in  any  year  thereafter,  in an  annual

   quantity greater than  15 percent of the baseline quantity of such

   substance produced by such person.

      "(C)  An  exception  authorized  under  this  subsection  shall

   terminate  no later  than January  1, 2010  (2012  in the  case of

   methyl chloroform).

Document info
Document views276
Page views276
Page last viewedFri Oct 21 13:15:00 UTC 2016